| Megan Hullinger, CNP | |
|
353 Fairmont Blvd, Rapid City, SD 57701-7375 | |
| (605) 755-4300 | |
| Not Available |
| Full Name | Megan Hullinger |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 353 Fairmont Blvd, Rapid City, South Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730962374 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | CP002918 (South Dakota) | Primary |
| Entity Name | Monument Health Rapid City Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275553463 PECOS PAC ID: 6002729506 Enrollment ID: O20070625000144 |
News Archive
The good news about health care spending continues. In the first nine months of this fiscal year, Medicare spending increased only 1.2 percent in nominal terms, and for 2014, it's now projected to be $1,000 lower per beneficiary than the Congressional Budget Office said it would be as recently as 2010. Even the Medicare trustees are starting to recognize that something big may be happening. In evaluating the recent deceleration, however, a crucial question remains: Can slower cost growth continue without harming the quality of outcomes? (Peter R. Orszag, 8/5).
Sexual activity declines in the year after heart attack for patients who don't get instructions from their doctors about when it's safe to resume sex, researchers reported at the American Heart Association's 11th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.
StemCells, Inc. announced today that is has received authorization from Swissmedic, the Swiss regulatory agency for therapeutic products, to initiate a Phase I/II clinical trial in Switzerland of the Company's proprietary HuCNS-SC® product candidate (purified human neural stem cells) in chronic spinal cord injury. The trial is designed to assess both safety and preliminary efficacy in patients with varying degrees of paralysis who are three to 12 months post-injury, and will progressively enroll patients based upon the severity of injury.
Maxim Pharmaceuticals has announced that based upon the negative outcome of it's confirmatory Phase 3 clinical trial (M0104) studying Ceplene(TM) (histamine dihydrochloride) in combination with Interleukin-2 (IL-2) in advanced malignant melanoma patients with liver metastases, it plans to close the treatment protocol approved by the FDA earlier this year.
Depression, known to be a condition with impaired psychosocial functioning that severely impacts the quality of life of patients and families, is actually defined with specific clinical symptoms such as sadness, difficulty to experience pleasure, sleep problems etc., present for at least two weeks. At least 40% of depressed patients actually benefit from an antidepressant treatment, whereas 20-30% of patients may suffer from chronic depression that negatively impacts their quality of life. In order to improve the efficiency of treatment and reduce the burden of depressive disorders, depression needs to be defined at the neurobiological level.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Megan Hullinger, CNP 353 Fairmont Blvd, Rapid City, SD 57701-7375 Ph: () - | Megan Hullinger, CNP 353 Fairmont Blvd, Rapid City, SD 57701-7375 Ph: (605) 755-4300 |
News Archive
The good news about health care spending continues. In the first nine months of this fiscal year, Medicare spending increased only 1.2 percent in nominal terms, and for 2014, it's now projected to be $1,000 lower per beneficiary than the Congressional Budget Office said it would be as recently as 2010. Even the Medicare trustees are starting to recognize that something big may be happening. In evaluating the recent deceleration, however, a crucial question remains: Can slower cost growth continue without harming the quality of outcomes? (Peter R. Orszag, 8/5).
Sexual activity declines in the year after heart attack for patients who don't get instructions from their doctors about when it's safe to resume sex, researchers reported at the American Heart Association's 11th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.
StemCells, Inc. announced today that is has received authorization from Swissmedic, the Swiss regulatory agency for therapeutic products, to initiate a Phase I/II clinical trial in Switzerland of the Company's proprietary HuCNS-SC® product candidate (purified human neural stem cells) in chronic spinal cord injury. The trial is designed to assess both safety and preliminary efficacy in patients with varying degrees of paralysis who are three to 12 months post-injury, and will progressively enroll patients based upon the severity of injury.
Maxim Pharmaceuticals has announced that based upon the negative outcome of it's confirmatory Phase 3 clinical trial (M0104) studying Ceplene(TM) (histamine dihydrochloride) in combination with Interleukin-2 (IL-2) in advanced malignant melanoma patients with liver metastases, it plans to close the treatment protocol approved by the FDA earlier this year.
Depression, known to be a condition with impaired psychosocial functioning that severely impacts the quality of life of patients and families, is actually defined with specific clinical symptoms such as sadness, difficulty to experience pleasure, sleep problems etc., present for at least two weeks. At least 40% of depressed patients actually benefit from an antidepressant treatment, whereas 20-30% of patients may suffer from chronic depression that negatively impacts their quality of life. In order to improve the efficiency of treatment and reduce the burden of depressive disorders, depression needs to be defined at the neurobiological level.
› Verified 6 days ago
Maria Sargent, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 353 Fairmont Blvd, Rapid City, SD 57701 Phone: 605-755-1000 | |
Kayla Sayer, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 640 Flormann St, Rapid City, SD 57701 Phone: 605-755-3300 | |
Jennifer Ann Erdman, CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 636 Saint Anne St, Rapid City, SD 57701 Phone: 605-348-8000 Fax: 605-348-4315 | |
Natasha Gray, DNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2805 5th St, Rapid City, SD 57701 Phone: 605-755-5700 | |
Morgan Folchert, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1760 Centre St Ste 2, Rapid City, SD 57703 Phone: 308-249-2912 | |
Paulette A Kirby, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 811 Columbus St, Rapid City, SD 57701 Phone: 605-343-3007 | |
Rebecca Bierle, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4150 5th St, Rapid City, SD 57701 Phone: 605-755-4300 |